Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin

Toxicology and Applied Pharmacology

Volumn 242, Issue 1, 2010, Pages 1-8

  Bratt, Jennifer M ^a   Franzi, Lisa M ^a   Linderholm, Angela L ^a   O'Roark, Erin M ^a   Kenyon, Nicholas J ^a   Last, Jerold A ^a  

^a CCRBM   (United States)

Author keywords

Airway hyperreactivity; Asthma; Eosinophil; Inflammation; l arginine; Nitric oxide; Nor NOHA

Indexed keywords

ARGINASE; ARGINASE 1; ARGINASE 2; ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) HYDROXYARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OVALBUMIN; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; ALLERGIC ASTHMA; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENZYME INHIBITION; EOSINOPHILIA; LUNG COMPLIANCE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; UPREGULATION;

AEROSOLS; AIRWAY RESISTANCE; ANIMALS; ARGINASE; ARGININE; BLOTTING, WESTERN; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LUNG; LUNG COMPLIANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OVALBUMIN; PNEUMONIA; RESPIRATORY HYPERSENSITIVITY;

ANIMALIA; MUS;

EID: 70449518026     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.09.018     Document Type: Article

References (41)

1. Bagnost T., Berthelot A., Bouhaddi M., Laurant P., André C., Guillaume Y., and Demougeot C. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-l-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat. J. Hypertens. 26 (2008) 1110-1118 PMID: 18475148
2. Berkowitz D.E., White R., Li D., Minhas K.M., Cernetich A., Kim S., Burke S., Shoukas A.A., Nyhan D., Champion H.C., and Hare J.M. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108 (2003) 2000-2006 PMID: 14517171
3. Bratt J.M., Franzi L.M., Linderholm A.L., Last M.S., Kenyon N.J., and Last J.A. Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol. Appl. Pharmacol. 234 (2009) 273-280 PMID: 19027033
4. Ckless K., Lampert A., Reiss J., Kasahara D., Poynter M.E., Irvin C.G.., Lundblad LK., Norton R., van der Vliet A., and Janssen-Heininger Y.M. Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. J. Immunol. 181 (2008) 4255-4264 PMID: 18768883
5. Ckless K., van der Vliet A., and Janssen-Heininger Y. Oxidative-nitrosative stress and post-translational protein modifications: implications to lung structure-function relations. Arginase modulates NF-kappaB activity via a nitric oxide-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 36 (2007) 645-653 PMID: 17218616
6. Closs E.I., Scheld J.S., Sharafi M., and Förstermann U. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol. Pharmacol. 57 (2000) 68-74 PMID: 10617680
7. El-Gayar S., Thuring-Nahler H., Pfeilschifter J., Rollinghoff M., and Bogdan C. Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. J. Immunol. 171 (2003) 4561-4568 PMID: 14568929
8. Escobales N., Rivera-Correa M., Altieri P.I., and Rodriguez J.F. Relationship between NO synthesis, arginine transport, and intracellular arginine levels in vascular smooth muscle cells. Amino Acids 19 (2000) 451-468 PMID: 11128552
9. Eynott P.R., Groneberg D.A., Caramori G., Adcock I.M., Donnelly L.E., Kharitonov S., Barnes P.J., and Chung K.F. Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness. Eur. J. Pharmacol. 452 (2002) 123-133 PMID: 12323393
10. Gobeil Jr. F., Zhu T., Brault S., Geha A., Vazquez-Tello A., Fortier A., Barbaz D., Checchin D., Hou X., Nader M., Bkaily G., Gratton J.P., Heveker N., Ribeiro-da-Silva A., Peri K., Bard H., Chorvatova A., D'Orléans-Juste P., Goetzl E.J., and Chemtob S. Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1. J. Biol. Chem. 281 (2006) 16058-16067 PMID: 16574649
11. Hirota K., Murata M., Sachi Y., Nakamura H., Takeuchi J., Mori K., and Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J. Biol. Chem. 274 (1999) 27891-27897 PMID: 10488136
12. Iniesta V., Gómez-Nieto L.C., and Corraliza I. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages. J. Exp. Med. 193 (2001) 777-784 PMID: 11257143
13. Iniesta V., Gómez-Nieto L.C., Molano I., Mohedano A., Carcelén J., Mirón C., Alonso C., and Corraliza I. Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol. 24 (2002) 113-118 PMID: 11982856
14. Jeyabalan G., Klune J.R., Nakao A., Martik N., Wu G., Tsung A., and Geller D.A. Arginase blockade protects against hepatic damage in warm ischemia-reperfusion. Nitric Oxide 19 (2008) 29-35 PMID: 18456004
15. Kenyon N.J., Bratt J.M., Linderholm A.L., Last M.S., and Last J.A. Arginases I and II in lungs of ovalbumin-sensitized mice exposed to ovalbumin: sources and consequences. Toxicol. Appl. Pharmacol. 230 (2008) 269-275 PMID: 18439639
16. Kenyon N.J., van der Vliet A., Schock B.C., Okamoto T., McGrew G.M., and Last J.A. Susceptibility to ozone-induced acute lung injury in iNOS-deficient mice. Am. J. Physiol. Lung Cell Mol. Physiol. 282 (2002) L540-L545 PMID: 11839550
17. Kenyon N.J., Ward R.W., and Last J.A. Airway fibrosis in a mouse model of airway inflammation. Toxicol. Appl. Pharmacol. 186 (2003) 90-100 PMID: 12639500
18. King N.E., Rothenberg M.E., and Zimmermann N. Arginine in asthma and lung inflammation. J. Nutr. 34 (2004) 2830S-2836S PMID: 15465795
19. Lara A., Khatri S.B., Wang Z., Comhair S.A., Xu W., Dweik R.A., Bodine M., Levison B.S., Hammel J., Bleecker E., Busse W., Calhoun W.J., Castro M., Chung K.F., Curran-Everett D., Gaston B., Israel E., Jarjour N., Moore W., and Erzurum S.C. Alterations of the arginine metabolome in asthma. Am. J. Respir. Crit. Care Med. 178 (2008) 673-681 PMID: 18635886
20. Lee J., Ryu H., Ferrante R.J., Morris S.M., and Ratan R.R. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginase paradox. Proc. Natl Acad. Sci. U.S.A. 100 (2003) 4843-4848 PMID: 12655043
21. Maarsingh H., Bossenga B.E., Bos I.S., Volders H.H., Zaagsma J., and Meurs H. l-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction. Eur. Respir. J. 34 (2009) 191-199 PMID: 19251784
22. Maarsingh H., Leusink J., Bos I.S., Zaagsma J., and Meurs H. Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma. Respir. Res. 7 (2006) 6-12 PMID: 16409620
23. Maarsingh H., Zuidhof A.B., Bos S.T., van Duin M., Boucher J., Zaagsma J., and Meurs H. Arginase inhibition protects against allergic airway obstruction, hyperresponsiveness & inflammation. Am. J. Respir. Crit. Care Med. 178 (2008) 565-573 PMID: 18583571
24. Martín L., Comalada M., Marti L., Closs E.I., MacLeod C.L., Martín del Río R., Zorzano A., Modolell M., Celada A., Palacín M., and Bertran J. Granulocyte-macrophage colony-stimulating factor increases l-arginine transport through the induction of CAT2 in bone marrow-derived macrophages. Am. J. Physiol. Cell Physiol. 290 (2005) C1364-C1372 PMID: 16371438
25. Meurs H., Hamer M.A., Pethe S., Vadon-Le Goff S., Boucher J.L., and Zaagsma J. Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity. Br. J. Pharmacol. 130 (2000) 1793-1798 PMID: 10952667
26. Meurs H., McKay S., Maarsingh H., Hamer M.A., Macic L., Molendijk N., and Zaagsma J. Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br. J. Pharmacol. 136 (2002) 391-398 PMID: 12023942
27. Morris C.R., Poljakovic M., Lavrisha L., Machado L., Kuypers F.A., and Morris Jr. S.M. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am. J. Respir. Crit. Care Med. 170 (2004) 148-153 PMID: 15070820
28. Nicholson B., Manner C.K., Kleeman J., and MacLeod C.L. Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J. Biol. Chem. 276 (2001) 15881-15885 PMID: 11278602
29. Nijkamp F.P., van der Linde H.J., and Folkerts G. Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Role of the epithelium. Am. Rev. Respir. Dis. 148 (1993) 727-734 PMID: 836864642
30. North M.L., Khanna N., Marsden P.A., Grasemann H., and Scott J.A. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am. J. Physiol. Lung Cell Mol. Physiol. 296 (2009) L911-L920
31. Reid K.M., Tsung A., Kaizu T., Jeyabalan G., Ikeda A., Shao L., Wu G., Murase N., and Geller D.A. Liver I/R injury is improved by the arginase inhibitor, N(omega)-hydroxy-nor-l-arginine (nor-NOHA). Am. J. Physiol. Gastrointest. Liver Physiol. 292 (2007) G512-G517 PMID: 17023552
32. Ricciardolo F.L. cNOS-iNOS paradigm and arginase in asthma. Trends Pharmacol. Sci. 24 (2003) 560-561 PMID: 14607075
33. Sarwar G., and Botting H.G. Rapid analysis of nutritionally important free amino acids in serum and organs (liver, brain, and heart) by liquid chromatography of precolumn phenylisothiocyanate derivatives. J. Assoc. Off. Anal. Chem. 73 (1990) 470-475 PMID: 2376555
34. Shen L.J., Beloussow K., and Shen W.C. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochem. Pharmacol. 69 (2005) 97-104 PMID: 15588718
35. Tadié J.M., Henno P., Leroy I., Danel C., Naline E., Faisy C., Riquet M., Levy M., Israël-Biet D., and Delclaux C. Role of nitric oxide synthase/arginase balance in bronchial reactivity in patients with chronic obstructive pulmonary disease. Am. J. Physiol. Lung Cell Mol. Physiol. 294 (2008) L489-L497
36. Takemoto K., Ogino K., Shibamori M., Gondo T., Hitomi Y., Takigawa T., Wang D.H., Takaki J., Ichimura H., Fujikura Y., and Ishiyama H. Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma. Am. J. Physiol. Lung Cell Mol. Physiol. 293 (2007) L1419-L1426 PMID: 17890324
37. Temelkovski J., Hogan S.P., Shepherd D.P., Foster P.S., and Kumar R.K. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 53 (1998) 849-856 PMID: 10193371
38. Ten Broeke R., De Crom R., Van Haperen R., Verweij V., Leusink-Muis T., Van Ark I., De Clerck F., Nijkamp F.P., and Folkerts G. Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. Respir. Res. 7 (2006) 58-70 PMID: 16597326
39. Topal G., Brunet A., Walch L., Boucher J.L., and David-Dufilho M. Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable l-arginine pools in human endothelial cells. J. Pharmacol. Exp. Ther. 318 (2006) 1368-1374 PMID: 16801455
40. Wu G., and Morris S.M. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336 (1998) 1-17 PMID: 9806879
41. Zimmermann N., King N.E., Laporte J., Yang M., Mishra A., Pope S.M., Muntel E.E., Witte D.P., Pegg A.A., Foster P.S., Hamid Q., and Rothenberg M.E. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J. Clin. Invest. 111 (2003) 1863-1874 PMID: 12813022